Sfoglia per AUTORE
ROSSI G
Collezione AOU Novara

  

Items : 20

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab. in Clinical and experimental medicine / Clin Exp Med. 2024 Aug 6;24(1):182. doi: 10.1007/s10238-024-01427-8.
2024
AOU San Luigi di Orbassano
AOU Novara

Gil-Bazo I; Baraibar I; Biello F; Rivoltini L; Chiari R; Baglivo S; Metro G; Passiglia F; Barletta G; Ludovini V; Rijavec E; Alama A; Dellepiane C; Dal Bello MG; Zullo L; Tagliamento M; Longo L; Vanni I; Rossi G; Ostano P; Santamaria S; Guana F; Chiorino G; Marconi S; Genova C; Novello S; Grossi F; Coco S;

Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago. in World journal of emergency surgery : WJES / World J Emerg Surg. 2024 Apr 16;19(1):14. doi: 10.1186/s13017-024-00543-w.
2024
AOU Alessandria
ASL VCO
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Agnoletti V; Catena F; Baiocchi GL; Bravi F; Vallicelli C; Coccolini F; Sartelli M; Banchini F; Capelli P; Reames S; Cairl N; Biffl WL; Truong HP; Schaffer K; Curtiss W; McClure A; Austin TR; Hyman TS; Quick JA; Hemmila M; Napolitano LM; Sangji NF; Armento I; Egodage T; Coffua LS; Echeverria-Rosario K; Ratnasekera A; Seng SS; Bardes JM; et alii...

2023
AO Cuneo
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Martinelli G; Rossi G; Volpi R; Sciumè M; Tarella C; Marconi G; Federico V; Romano A; Cardinali V; Gigli F; Roncoroni E; Ferrara F; Maurillo L; Nanni J; Rivellini F; Cascavilla N; Fianchi L; Cilloni D; Lanza F; Abruzzese E; Martini V; Lunghi M; Molteni A; Gottardi M; Salutari P; Cairoli R; Borlenghi E; Basilico CM; Manfra I; et alii...

Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy. in Leukemia research / Leuk Res. 2023 Apr;127:107040. doi: 10.1016/j.leukres.2023.107040. Epub 2023 Feb 14.
2023
AOU Novara

Maurillo L; Spagnoli A; Candoni A; Papayannidis C; Borlenghi E; Lazzarotto D; Fianchi L; Sciumè M; Zannier ME; Buccisano F; Del Principe MI; Mancini V; Breccia M; Fanin R; Todisco E; Lunghi M; Palmieri R; Fracchiolla N; Musto P; Rossi G; Venditti A;

Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer. in Expert review of respiratory medicine / Expert Rev Respir Med. 2021 Nov;15(11):1427-1435. doi: 10.1080/17476348.2021.1987887. Epub 2021 Oct
2021
AOU Novara

Rijavec E; Genova C; Biello F; Rossi G; Indini A; Grossi F;

2021
AOU Novara

Bauckneht M; Genova C; Rossi G; Rijavec E; Dal Bello MG; Ferrarazzo G; Tagliamento M; Donegani MI; Biello F; Chiola S; Zullo L; Raffa S; Lanfranchi F; Cittadini G; Marini C; Lopci E; Sambuceti G; Grossi F; Morbelli S;

Long-term follow-up of recovered MPN patients with COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.
2021
AOU Città della Salute di Torino
AOU Novara

Guglielmelli P; Benajiba L; Bellosillo B; Cavalca F; Curto-Garcia N; Garrote M; Bellini M; Daffini R; Sobas MA; Cattaneo D; Cuevas B; Koschmieder S; Ruggeri M; Xicoy Cirici B; Angona A; Lopez Abadia E; Hernandez-Boluda JC; De Stefano V; Lunghi F; Bonifacio M; Garcia-Gutierrez V; Magro Mazo E; Navas Elorza B; Patriarca A; Rumi E; Osorio S; Benevolo G; Fox ML; Sagues Serrano M; et alii...

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. in Leukemia / Leukemia. 2021 Feb;35(2):485-493. doi: 10.1038/s41375-020-01107-y. Epub 2021 Jan 7.
2021
AOU Città della Salute di Torino
AOU Novara

Bellosillo B; Benajiba L; Curto-Garcia N; Bellini M; Daffini R; Cavalca F; Cattaneo D; Garrote M; Guglielmelli P; Cirici BX; Abadia EL; Cuevas B; Koschmieder S; Hernandez-Boluda JC; Ruggeri M; Mazo EM; Angona A; Elorza BN; Lunghi F; Patriarca A; Sobas MA; Serrano MS; Carreno-Tarragona G; Bonifacio M; Cervantes KSQ; Papadopoulos P; Rumi E; Osorio S; Morcillo CM; et alii...

Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Sep;22(9):1603-1610. doi: 10.1007/s12094-020-02305-x. Epub 2020 Feb 11.
2020
AOU Novara

Coco S; Spallarossa P; Alama A; Tagliamento M; Biello F; Rossi G; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Carbone F; Grossi F; Bonaventura A; Dallegri F; Genova C; Montecucco F;

2020
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Ghia P; Cuneo A; Foà R; Montserrat E; Rambaldi A; Rossi G; Stamatopoulos K; Coscia M; Tam C; Zdrenghea M; Strugov V; Stavroyianni N; Stanca O; Shrestha A; Shah N; Rossi D; Papaioannou M; Ortiz Pareja M; Kalashnikova O; Enrico A; Hakobyan Y; Doubek M; Dimou M; Andres M; Nikitin E; Dos Santos G; Chiarenza A; Barna G; Pocali B; et alii...

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Novello S; Di Maio M; Tiseo M; Galetta D; Bria E; Rossi G; Tabbò F; Cortinovis D; Rizzo P; Delmonte A; Bareggi C; Del Conte A; Sergi C; Casartelli C; Gregorc V; Graziano P; Rossi A; Maiello E; Scotti V; Martelli O; Borra G; Riccardi F; Osman G; Cappuzzo F; Cecere F; Pilotto S; Ghilardi L; Bordi P; Gobbini E; et alii...

Targeted therapy of oncogenic-driven advanced non-small cell lung cancer: recent advances and new perspectives. in Expert review of respiratory medicine / Expert Rev Respir Med. 2020 Apr;14(4):367-383. doi: 10.1080/17476348.2020.1714441. Epub 2020 Jan 17.
2020
AOU Novara

Genova C; Rossi G; Tagliamento M; Rijavec E; Biello F; Cerbone L; Zullo L; Grossi F;

Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. in Journal of clinical medicine / J Clin Med. 2019 Oct 1;8(10):1566. doi: 10.3390/jcm8101566.
2019
AOU Novara

Genova C; Boccardo S; Mora M; Rijavec E; Biello F; Rossi G; Tagliamento M; Dal Bello MG; Coco S; Alama A; Vanni I; Barletta G; Bianchi R; Maggioni C; Bruzzi P; Grossi F;

Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer. in Clinical & experimental metastasis / Clin Exp Metastasis. 2019 Oct;36(5):449-456. doi: 10.1007/s10585-019-09984-z. Epub 2019 Aug 2.
2019
AOU Novara

Genova C; Dallegri F; Coco S; Spallarossa P; Biello F; Rossi G; Alama A; Tagliamento M; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Bonaventura A; Grossi F; Carbone F; Montecucco F;

2019
AOU Città della Salute di Torino
AOU Novara

Arcaini L; Meli E; Pagani C; Nassi L; Ferrari A; Botto B; Rattotti S; Cavallo F; Marcheselli L; Anastasia A; Chiarenza A; Rusconi C; Federico M; Rossi G;

2019
AOU Novara

Cavalieri Z; Longo L; Biello F; Rijavec E; Boccardo S; Rosa A; Giovanna Dal Bello M; Tagliamento M; Fontana V; Rossi G; Genova C; Coco S; Alama A; Bruzzo C; Grossi F;

Nivolumab treatment in advanced lung cancer patient with chronic active hepatitis C and systemic lupus erythematosus. in Immunotherapy / Immunotherapy. 2019 Jul;11(10):873-879. doi: 10.2217/imt-2019-0025. Epub 2019 Jun 3.
2019
AOU Novara

Rossi G; Rijavec E; Genova C; Paolino S; Grossi F; Tagliamento M; Biello F; De Maria A;

Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2019 Aug;68(8):1351-1358. doi: 10.1007/s00262-019-02367-z. Epub 2019 Jul
2019
AOU Novara

Dallegri F; Coco S; Spallarossa P; Alama A; Tagliamento M; Biello F; Rossi G; Dal Bello MG; Rijavec E; Ferrara D; Ansaldo AM; Elia E; Bardi N; Minetti S; Vecchié A; Carbone F; Grossi F; Bonaventura A; Genova C; Montecucco F;

Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. in American journal of hematology / Am J Hematol. 2018 Sep;93(9):E243-E246. doi: 10.1002/ajh.25212. Epub 2018 Aug 25.
2018
AOU Novara

Barcellini W; Zaninoni A; Fattizzo B; Giannotta JA; Lunghi M; Ferrari A; Leporace AP; Maschio N; Scaramucci L; Cantoni S; Chiurazzi F; Consonni D; Rossi G; De Fabritiis P; Gaidano G; Zanella A; Cortelezzi A;

Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2014 Jun;15(7):730-7. doi: 10.1016/S1470-2045(14)70191-3. Epub 2014 May 13.
2014
AOU Città della Salute di Torino
AOU Novara

Zanni M; Gaudiano M; Congiu A; Castellino A; Dreyling M; Botto B; Zaccaria A; Fattori PP; Salvi F; Zinzani P; Molinari AL; Liberati AM; Ladetto M; Pavone V; Spina M; Inghirami G; Baldi I; Carella AM; Franceschetti S; Chiappella A; Vitolo U; Ciccone G; Gaidano G; Rossi G;